| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CI | Common Stock, $.01 Par Value | Award | $0 | +18.8K | +12.29% | $0.00 | 172K | Feb 25, 2022 | Direct | F1 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | -$1.15M | -5.01K | -2.92% | $229.64 | 167K | Feb 25, 2022 | Direct | F2 |
| transaction | CI | Common Stock, $.01 Par Value | Tax liability | -$2M | -8.7K | -5.22% | $229.64 | 158K | Feb 25, 2022 | Direct | F3 |
| transaction | CI | Common Stock, $.01 Par Value | Sale | -$2.3M | -10.1K | -6.38% | $228.70 | 148K | Feb 28, 2022 | Direct | F4 |
| holding | CI | Common Stock, $.01 Par Value | 1.67K | Feb 25, 2022 | By 401(k) | F5 | |||||
| holding | CI | Common Stock, $.01 Par Value | 371K | Feb 25, 2022 | By GRAT | ||||||
| holding | CI | Common Stock, $.01 Par Value | 39.8K | Feb 25, 2022 | By Trust |
| Id | Content |
|---|---|
| F1 | The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2019-2021 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. |
| F2 | Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
| F3 | Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| F4 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021. |
| F5 | Represents shares acquired through ongoing participation in Cigna's 401(k) Plan. |